Use our pre-submission checklist
Avoid common mistakes on your manuscript.
1 Erratum to: Drugs (2016) 76(8):907–911 DOI 10.1007/s40265-016-0583-2
Page 908, table entitled ‘Features and properties of reslizumab’
The third row, Mechanism of Action, which previously read:
Interleukin 5 receptor antagonist
Should read:
Interleukin 5 inhibitor
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s40265-016-0583-2.
Rights and permissions
About this article
Cite this article
Markham, A. Erratum to: Reslizumab: First Global Approval. Drugs 76, 1159 (2016). https://doi.org/10.1007/s40265-016-0608-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-016-0608-x